Skip to main content

Main menu

  • Home
  • Articles
    • Current
    • Published Ahead of Print
    • Archive
    • Supplemental Issues
    • Collections - French
    • Collections - English
  • Info for
    • Authors & Reviewers
    • Submit a Manuscript
    • Advertisers
    • Careers & Locums
    • Subscribers
    • Permissions
  • About CFP
    • About CFP
    • About the CFPC
    • Editorial Advisory Board
    • Terms of Use
    • Contact Us
  • Feedback
    • Feedback
    • Rapid Responses
    • Most Read
    • Most Cited
    • Email Alerts
  • Blogs
    • Latest Blogs
    • Blog Guidelines
    • Directives pour les blogues
  • Mainpro+ Credits
    • About Mainpro+
    • Member Login
    • Instructions
  • Other Publications
    • http://www.cfpc.ca/Canadianfamilyphysician/
    • https://www.cfpc.ca/Login/
    • Careers and Locums

User menu

  • My alerts

Search

  • Advanced search
The College of Family Physicians of Canada
  • Other Publications
    • http://www.cfpc.ca/Canadianfamilyphysician/
    • https://www.cfpc.ca/Login/
    • Careers and Locums
  • My alerts
The College of Family Physicians of Canada

Advanced Search

  • Home
  • Articles
    • Current
    • Published Ahead of Print
    • Archive
    • Supplemental Issues
    • Collections - French
    • Collections - English
  • Info for
    • Authors & Reviewers
    • Submit a Manuscript
    • Advertisers
    • Careers & Locums
    • Subscribers
    • Permissions
  • About CFP
    • About CFP
    • About the CFPC
    • Editorial Advisory Board
    • Terms of Use
    • Contact Us
  • Feedback
    • Feedback
    • Rapid Responses
    • Most Read
    • Most Cited
    • Email Alerts
  • Blogs
    • Latest Blogs
    • Blog Guidelines
    • Directives pour les blogues
  • Mainpro+ Credits
    • About Mainpro+
    • Member Login
    • Instructions
  • RSS feeds
  • Follow cfp Template on Twitter
LetterLetters

Relationship with pharmaceutical companies

Margot A. Walker
Canadian Family Physician November 2015, 61 (11) 945;
Margot A. Walker
Nanaimo, BC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • eLetters
  • Info & Metrics
  • PDF
Loading

I thank Dr Lemire for her response1 to Drs Spithoff, Lexchin, and Kitai,2 who are eager to cut ties with the health care and pharmaceutical industry. I am very grateful to the pharmaceutical industry and am embarrassed by the lack of acknowledgment afforded to it by some groups in our profession. In the course of my career I have regularly attended medical conferences and meetings fully or partially funded by the pharmaceutical industry and have been excited to hear about new medications. I have been equally excited to return to my practice and advise my patients that relief might be on the horizon for them. While I am cautioned by the adage “Be not the first by whom the new is tried nor the last to lay the old aside,” I and my patients wait for feedback from other specialist colleagues on the efficacy and side effect profiles of new medications.

I recall the excitement of attending pharmaceutical industry–sponsored meetings to hear about proton pump inhibitors, angiotensin-converting enzyme inhibitors, selective serotonin reuptake inhibitors, and more recently, glucagonlike peptide 1 agonists, sodium-glucose cotransporter inhibitors, α1-proteinase inhibitors, 5-hydroxytryptamine receptor agonists, and ulipristal—all of which were generated because of the investment, research, and development of pharmaceutical companies.

When I arrive home at the end of a busy day, and have committed to go out that evening to listen to a pharmaceutical industry–sponsored talk given by a practising specialist and eat a pharmaceutical industry–sponsored meal, most times my preference would be to stay at home. I nevertheless attend the gathering and listen to the speaker and the questions and discussions of my colleagues—most of whom are gray-haired, I might add. I always learn something. My patients expect me to talk to them about the benefits of exercise and eating a healthy diet, and they also expect me to have current knowledge about new drugs from which they might benefit.

Footnotes

  • Competing interests

    None declared

  • Copyright© the College of Family Physicians of Canada

References

  1. 1.↵
    1. Lemire F
    . Response [Letters]. Can Fam Physician 2015;61:669.
    OpenUrlFREE Full Text
  2. 2.↵
    1. Spithoff SM,
    2. Lexchin J,
    3. Kitai C
    . Complete dissociation from the health care and pharmaceutical industry [Letters]. Can Fam Physician 2015;61:668-9.
    OpenUrlFREE Full Text
PreviousNext
Back to top

In this issue

Canadian Family Physician: 61 (11)
Canadian Family Physician
Vol. 61, Issue 11
1 Nov 2015
  • Table of Contents
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on The College of Family Physicians of Canada.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Relationship with pharmaceutical companies
(Your Name) has sent you a message from The College of Family Physicians of Canada
(Your Name) thought you would like to see the The College of Family Physicians of Canada web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Relationship with pharmaceutical companies
Margot A. Walker
Canadian Family Physician Nov 2015, 61 (11) 945;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Share
Relationship with pharmaceutical companies
Margot A. Walker
Canadian Family Physician Nov 2015, 61 (11) 945;
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Footnotes
    • References
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Excellent chronic pain guideline
  • Treating the vaccine hesitant
  • Francophone participation at Family Medicine Forum
Show more Letters

Similar Articles

Navigate

  • Home
  • Current Issue
  • Archive
  • Collections - English
  • Collections - Française

For Authors

  • Authors and Reviewers
  • Submit a Manuscript
  • Permissions
  • Terms of Use

General Information

  • About CFP
  • About the CFPC
  • Advertisers
  • Careers & Locums
  • Editorial Advisory Board
  • Subscribers

Journal Services

  • Email Alerts
  • Twitter
  • RSS Feeds

Copyright © 2022 by The College of Family Physicians of Canada

Powered by HighWire